Cellartis
Founded Year
2001Stage
Acquired | AcquiredTotal Raised
$16.02MAbout Cellartis
Provider of human embryonic stem (hES) cell-based products and technologies. The company provides characterized hES cell lines, culture media, tools, feeder cells, and training courses to clinical researchers worldwide. Its primary focus is on drug discovery applications and toxicity testing based on hES cells.
Cellartis Headquarter Location
Biotech Center Arvid Wallgrens Backe 20
Gothenburg, 413 46,
Sweden
46 31 758 09 00
Cellartis Patents
Cellartis has filed 3 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
7/18/2008 | 2/10/2015 | Drug discovery, Developmental biology, Embryology, Transcription factors, Stem cells | Grant |
Application Date | 7/18/2008 |
|---|---|
Grant Date | 2/10/2015 |
Title | |
Related Topics | Drug discovery, Developmental biology, Embryology, Transcription factors, Stem cells |
Status | Grant |
When was Cellartis founded?
Cellartis was founded in 2001.
Where is Cellartis's headquarters?
Cellartis's headquarters is located at Biotech Center, Gothenburg.
What is Cellartis's latest funding round?
Cellartis's latest funding round is Acquired.
How much did Cellartis raise?
Cellartis raised a total of $16.02M.
Who are the investors of Cellartis?
Investors of Cellartis include Cellectis, Biofund, T-bolaget, National Institutes of Health and Vitrolife.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.